Page last updated: 2024-12-11

demethylwedelolactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

demethylwedelolactone: antihepatotoxic coumestan; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5489605
CHEMBL ID2089002
CHEBI ID191036
SCHEMBL ID3364302
MeSH IDM0145638

Synonyms (27)

Synonym
demethylwedelolactone
1,3,8,9-tetrahydroxy-[1]benzofuro[3,2-c]chromen-6-one
SCHEMBL3364302
LMPK12090041
norwedelolactone
1,3,8,9-tetrahydroxy-[1]benzouro[3,2-c]chromen-6-one
CHEBI:191036
6468-55-9
unii-uxn2kxv8bb
6h-benzofuro(3,2-c)(1)benzopyran-6-one, 1,3,8,9-tetrahydroxy-
uxn2kxv8bb ,
AKOS015897135
CHEMBL2089002
1,3,8,9-tetrahydroxy-6h-benzofuro[3,2-c]chromen-6-one
desmethylwedelolactone
FT-0698755
DTXSID00214968
1,3,8,9-tetrahydroxycoumestan
1,3,8,9-tetrahydroxy-6h-benzofuro-[3,2-c]chromen-6-one
HY-N2028
ZB1880
1,3,8,9-tetrahydroxy-6h-benzofuro(3,2-c)chromen-6-one
1,3,8,9-tetrahydroxy-6h-benzofuro(3,2-c)(1)benzopyran-6-one
CS-0018519
MS-24319
AC-34923
A867843
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
coumestansMembers of the class of benzofurochromene with a 6H-[1]benzofuro[3,2-c]chromene skeleton and its substituted derivatives. They are the 3,4-didehydroderivatives of pterocarpans.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID684275Inhibition of IkappaBalpha phosphorylation in human MDA-MB-231 cells at 5 to 20 uM after 3 to 24 hrs by Western blot analysis2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684084Downregulation of MMP9 expression in human MDA-MB-231 cells at 0.1 to 0.9 uM after 12 hrs by Western blot analysis2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684089Upregulation of TIMP2 expression in human MDA-MB-231 cells at 1.1 to 3.6 uM after 12 hrs by Western blot analysis2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684285Antiinvasive activity against human MDA-MB-231 cells xenografted in athymic nude BALB/c mouse assessed as decrease in lung metastasis at 5 and 20 mg/kg, ip administered 3 times per week starting 1 week prior to xenografting measured after 5 weeks by hemat2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684081Inhibition of MMP2 in human MDA-MB-231 cells at 20 uM up to 12 hrs by gelatin-zymogrphy2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684077Antimetastatic activity against human MDA-MB-231 cells assessed as inhibition of wound closure activity up to 20 uM at 12 hrs by scratch motility assay2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684075Cytotoxicity against human MDA-MB-231 cells at 25 to 100 uM after 24 hrs by MTT assay2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684086Upregulation of TIMP1 expression in human MDA-MB-231 cells at 0.2 to 0.8 uM after 12 hrs by Western blot analysis2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684083Downregulation of MMP2 expression in human MDA-MB-231 cells at 5 to 20 uM after 12 hrs by Western blot analysis2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684079Inhibition of FAK phosphorylation in human MDA-MB-231 cells after 12 hrs by Western blot analysis2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684286Antiinvasive activity against human SKHEP1 cells2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684278Inhibition of ERK 1/2 phosphorylation in human MDA-MB-231 cells at 5 to 20 uM after 12 hrs by Western blot analysis2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684078Antiinvasive activity against human MDA-MB-231 cells assessed as F-actin reorganization at 20 uM incubated 24 hrs post-serum starvation measured after 12 hrs by TRITC-conjugated phalloidin staining method2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684283Antiinvasive activity against human MDA-MB-231 cells xenografted in athymic nude BALB/c mouse assessed as decrease in lung size at 5 and 20 mg/kg, ip administered 3 times per week starting 1 week prior to xenografting measured after 5 weeks relative to co2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684082Inhibition of MMP9 in human MDA-MB-231 cells at 20 uM up to 12 hrs by gelatin-zymogrphy2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684080Antiinvasive activity against human MDA-MB-231 cells pretreated for 12 hrs followed by compound-wash out measured after 12 hrs by Boyden chamber assay2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684284Antiinvasive activity against human MDA-MB-231 cells xenografted in athymic nude BALB/c mouse assessed as decrease in lung weight at 5 and 20 mg/kg, ip administered 3 times per week starting 1 week prior to xenografting measured after 5 weeks relative to 2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684076Antimetastatic activity against human MDA-MB-231 cells assessed as inhibition of anchorage-independent colony formation after 21 days by inverted microscopy2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
AID684277Inhibition of IkappaBalpha phosphorylation in human MDA-MB-231 cells after 12 hrs by Western blot analysis2012European journal of medicinal chemistry, Oct, Volume: 56Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.71 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]